Literature DB >> 15634793

A thallium-sensitive, fluorescence-based assay for detecting and characterizing potassium channel modulators in mammalian cells.

C David Weaver1, David Harden, Steven I Dworetzky, Barbara Robertson, Ronald J Knox.   

Abstract

Potassium channels have been identified as targets for a large number of therapeutic indications. The ability to use a high-throughput functional assay for the detection and characterization of small-molecule modulators of potassium channels is very desirable. However, present techniques capable of screening very large chemical libraries are limited in terms of data quality, temporal resolution, ease of use, and requirements for specialized instrumentation. To address these issues, the authors have developed a fluorescence-based thallium flux assay. This assay is capable of detecting modulators of both voltage and ligand-gated potassium channels expressed in mammalian cells. The thallium flux assay can use instruments standard to most high-throughput screening laboratories, and using such equipment has been successfully employed to screen large chemical libraries consisting of hundreds of thousands of compounds.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15634793     DOI: 10.1177/1087057104268749

Source DB:  PubMed          Journal:  J Biomol Screen        ISSN: 1087-0571


  60 in total

1.  Profiling diverse compounds by flux- and electrophysiology-based primary screens for inhibition of human Ether-à-go-go related gene potassium channels.

Authors:  Beiyan Zou; Haibo Yu; Joseph J Babcock; Pritam Chanda; Joel S Bader; Owen B McManus; Min Li
Journal:  Assay Drug Dev Technol       Date:  2010-12       Impact factor: 1.738

2.  Further optimization of the K-Cl cotransporter KCC2 antagonist ML077: development of a highly selective and more potent in vitro probe.

Authors:  Eric Delpire; Aleksandra Baranczak; Alex G Waterson; Kwangho Kim; Nathan Kett; Ryan D Morrison; J Scott Daniels; C David Weaver; Craig W Lindsley
Journal:  Bioorg Med Chem Lett       Date:  2012-06-07       Impact factor: 2.823

Review 3.  High throughput screening technologies for ion channels.

Authors:  Hai-bo Yu; Min Li; Wei-ping Wang; Xiao-liang Wang
Journal:  Acta Pharmacol Sin       Date:  2015-12-14       Impact factor: 6.150

4.  Small-molecule screen identifies inhibitors of the neuronal K-Cl cotransporter KCC2.

Authors:  Eric Delpire; Emily Days; L Michelle Lewis; Dehui Mi; Kwangho Kim; Craig W Lindsley; C David Weaver
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-11       Impact factor: 11.205

5.  Direct control of Na(+)-K(+)-2Cl(-)-cotransport protein (NKCC1) expression with aldosterone.

Authors:  Bo Ding; Robert D Frisina; Xiaoxia Zhu; Yoshihisa Sakai; Bernd Sokolowski; Joseph P Walton
Journal:  Am J Physiol Cell Physiol       Date:  2013-10-30       Impact factor: 4.249

6.  High-throughput screening reveals a small-molecule inhibitor of the renal outer medullary potassium channel and Kir7.1.

Authors:  L Michelle Lewis; Gautam Bhave; Brian A Chauder; Sreedatta Banerjee; Katharina A Lornsen; Rey Redha; Katherine Fallen; Craig W Lindsley; C David Weaver; Jerod S Denton
Journal:  Mol Pharmacol       Date:  2009-08-25       Impact factor: 4.436

7.  A novel mitochondrial K(ATP) channel assay.

Authors:  Andrew P Wojtovich; David M Williams; Marcin K Karcz; Coeli M B Lopes; Daniel A Gray; Keith W Nehrke; Paul S Brookes
Journal:  Circ Res       Date:  2010-02-25       Impact factor: 17.367

8.  Closure of mitochondrial potassium channels favors opening of the Tl(+)-induced permeability transition pore in Ca(2+)-loaded rat liver mitochondria.

Authors:  Sergey M Korotkov; Irina V Brailovskaya; Anton R Shumakov; Larisa V Emelyanova
Journal:  J Bioenerg Biomembr       Date:  2015-04-14       Impact factor: 2.945

9.  High-throughput screening for small-molecule modulators of inward rectifier potassium channels.

Authors:  Rene Raphemot; C David Weaver; Jerod S Denton
Journal:  J Vis Exp       Date:  2013-01-27       Impact factor: 1.355

10.  Discovery of 5-Phenyl-N-(pyridin-2-ylmethyl)-2-(pyrimidin-5-yl)quinazolin-4-amine as a Potent I Kur Inhibitor.

Authors:  Heather J Finlay; James A Johnson; John L Lloyd; Ji Jiang; James Neels; Prashantha Gunaga; Abhisek Banerjee; Naveen Dhondi; Anjaneya Chimalakonda; Sandhya Mandlekar; Mary Lee Conder; Harinath Sale; Dezhi Xing; Paul Levesque; Ruth R Wexler
Journal:  ACS Med Chem Lett       Date:  2016-06-09       Impact factor: 4.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.